Table of Contents
PPT Slide
PPT Slide
Our Mission
PPT Slide
A Review of 2002
Differentiated Oral Drug Delivery
Emisphere Business Model
Partnership Focus
“Focus on the Client”
Current Cash and Assets
Competitive Advantage
Oral Salmon Calcitonin
Oral PTH 1-34 (teraparatide)
Oral rhGH (somatotropin)
Feasibility Programs
Business Strategy for 2003
Development
PPT Slide
PROTECT: The Foundation for the Solid Formulation
Analysis Presented at ASH
PPT Slide
PPT Slide
PPT Slide
Heparin Solid Formulation: Progress
Clinical Studies
PPT Slide
Oral Delivery
Emisphere’s Oral Insulin Candidate
Development Progress
Next Steps
Aggregate Market Opportunity† 2002
Translating the Market Potential: Emisphere’s Inherent Opportunity
Oral Cromolyn Sodium
Clinical Data Summary: Multi-Dose Study
Established Technology Platform
2003
PPT Slide
|
Author: Shepard M. Goldberg
|